AzTrials
AzTrials

Anterior Shoulder DislocationSR-SDNCT02787395

Self Reduction of Shoulder Dislocation

A study testing shoulder dislocation self reduction in people with Anterior Shoulder Dislocation, run by Tel-Aviv Sourasky Medical Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Anterior dislocation of the shoulder (glenohumeral joint) is one of the most prevalent dislocations. Following a first dislocation recurrence rates of up to 80% have been reported. Many patients will seek medical assistance for reduction of the shoulder after each of these recurrent dislocations. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Anterior Shoulder Dislocation
What is being tested?
shoulder dislocation self reduction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
No sites listed yet
Study dates
Jun 2016to Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • anterior shoulder dislocation
  • acute (24 hours) shoulder dislocation

Who cannot join

  • shoulder fracture
  • non-cooperative patient

About this study

Official title: Patients Education of a Self-reduction Technique for Anterior Dislocation of Shoulder

Anterior dislocation of the shoulder (glenohumeral joint) is one of the most prevalent dislocations. Following a first dislocation recurrence rates of up to 80% have been reported. Many patients will seek medical assistance for reduction of the shoulder after each of these recurrent dislocations. The investigators describe the results of reduction of anterior glenohumeral dislocation using a modified self manipulated Milch technique that can be performed by the patients themselves after simple guidance and demonstration. This method is directed to patients who are not willing or cannot have surgical stabilization and may be in a place where medical assistance is not available.

Being tested
shoulder dislocation self reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • shoulder dislocation self reductionProcedure or surgery

    shoulder dislocation self reduction using one of three methods in the study

Study groups in NCT02787395
Study groupRoleWhat they receive
MilchExperimentalmodified Milch technique for self reduction
Receives: Procedure: shoulder dislocation self reduction
Boss HoltzachExperimentalBoss Holtzach technique for self reduction
Receives: Procedure: shoulder dislocation self reduction
StimsonExperimentalStimson technique for self reduction
Receives: Procedure: shoulder dislocation self reduction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. rate of successfull self reduction

    the number/rate of successful reductions using each technique will be calculated

    Measured: 10 minutes

Secondary outcomes (2)
  1. pain using VAS during reduction

    patients will be asked to report pain levels using VAS during the self reduction procedure

    Measured: 10 minutes

  2. patient satisfaction from self reduction process using VAS

    patients will be asked to report their satisfaction from self reduction process using VAS

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionJun 2017 (estimated)
  4. Study completionJun 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02787395
Sponsor's protocol ID
TASMC-15-OC-0612-CTIL
Acronym
SR-SD
Status last verified
May 2016
First submitted
22 May 2016
Last updated
3 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing shoulder dislocation self reduction in people with Anterior Shoulder Dislocation, run by Tel-Aviv Sourasky Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

rate of successfull self reduction (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in